The results revealed a 25%–30% reduction in the expression of ABCB1 and ABCG2, which encode for P-glycoprotein and breast cancer resistance protein, respectively, in NFIB-overexpressed vs. control cells (P < .05; Fig. 3). The gene discussed is ABCG2; the disease is cancer.